Items where authors include "Bethune, C"

Article

Hardt, K, Vandebosch, A, Sadoff, J et al. (285 more authors) (2022) Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Infectious Diseases, 22 (12). pp. 1703-1715. ISSN 1473-3099

Shields, AM, Tadros, S, Al-Hakim, A et al. (20 more authors) (2022) Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. Frontiers in Immunology, 13. 984376. ISSN 1664-3224

Shields, AM, Faustini, SE, Hill, HJ et al. (22 more authors) (2022) SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study. Journal of Clinical Immunology, 42 (5). pp. 923-934. ISSN 0271-9142

Shields, AM, Faustini, SE, Hill, HJ et al. (25 more authors) (2022) Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study. Frontiers in Immunology, 13. 912571. ISSN 1664-3224

Bethune, C, Egner, W, Garcez, T et al. (8 more authors) (2019) British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders. Clinical & Experimental Immunology, 196 (3). pp. 328-335. ISSN 0009-9104

Dorjbal, B, Stinson, JR, Ma, CA et al. (52 more authors) (2019) Hypomorphic CARD11 mutations associated with diverse immunologic phenotypes with or without atopic disease. The Journal of Allergy and Clinical Immunology, 143 (4). pp. 1482-1495. ISSN 0091-6749

Whitworth, J, Smith, PS, Martin, J-E et al. (330 more authors) (2018) Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes. The American Journal of Human Genetics, 103 (1). pp. 3-18. ISSN 0002-9297